Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 1.00 |
| ▸ | CYP2C8 | P10632 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 3/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.98 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.98 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.98 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.61 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gingerol SCHEMBL2121898 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL17368634 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL30767163 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| Gingerol SCHEMBL32102 | 1.00 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL4883453 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL20668234 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL17301613 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL20668179 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL17301612 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 | |
| SCHEMBL4885722 | 0.99 | LTA4H (1.00) | LTA4HCYP3A4TRPV1CYP2C8CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023031860-A1 | COMPOSITIONS, KITS, AND METHODS TO PROVIDE SYNERGISTIC AND/OR ADDITIVE EFFECTS FROM COMPRISED INGREDIENTS FOR THE PREVENTION, TREATMENT AND MANAGEMENT OF NAUSEA AND VOMITING. | PATEL, Natvarlal Hargovinddas (IN) | 2023-03-09 | — | — | WO | claimed |
| WO-2023031861-A1 | COMPOSITIONS, KITS, AND METHODS FOR TREATMENT OF NAUSEA AND VOMITING | PATEL, Natvarlal Hargovinddas (IN) | 2023-03-09 | — | — | WO | claimed |
| WO-2023031779-A1 | COMPOSITIONS, KITS, AND METHODS TO PROVIDE SYNERGISTIC AND/OR ADDITIVE EFFECTS FROM COMPRISED INGREDIENTS FOR THE PREVENTION, TREATMENT AND MANAGEMENT OF NAUSEA AND VOMITING | PATEL, Natvarlal Hargovinddas (IN) | 2023-03-09 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-12590115-B2 | Technologies useful for oligonucleotide preparation | WAVE LIFE SCIENCES LTD. (SG) | 2026-03-31 | — | — | US | disclosed |
| US-20260055133-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD (SG) | 2026-02-26 | — | — | US | disclosed |
| EP-4680210-A1 | MEDICAL PATCH COMPRISING SKIN IRRITATING ACTIVE AGENT | LTS Lohmann Therapie-Systeme AG (DE) | 2026-01-21 | — | — | EP | disclosed |
| US-20260008806-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD (SG) | 2026-01-08 | — | — | US | disclosed |
| US-12435105-B2 | Technologies for oligonucleotide preparation | WAVE LIFE SCIENCES LTD. (SG) | 2025-10-07 | — | — | US | disclosed |
| WO-2025202300-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | NEKTIUM PHARMA S.L. (ES) | 2025-10-02 | — | — | WO | disclosed |
| EP-4623703-A1 | COMPLEX COACERVATES FOR NUTRACEUTICALS | Nektium Pharma S.L. (ES) | 2025-10-01 | — | — | EP | disclosed |
| US-12428442-B2 | Compounds, compositions and methods for synthesis | WAVE LIFE SCIENCES LTD. (SG) | 2025-09-30 | — | — | US | disclosed |
| US-11541019-B2 | Compositions for use in the treatment of diabetes | UNIVERSITY OF ULSTER (GB) | 2023-01-03 | — | — | US | disclosed |
| WO-2022238249-A2 | PROCESS OF MAKING GINGEROL COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH SA (CH) | 2022-11-17 | — | — | WO | disclosed |
| US-20220356204-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | WAVE LIFE SCIENCES LTD. (SG) | 2022-11-10 | — | — | US | disclosed |
| CN-110087664-B | Compositions and methods for treating orthopedic disorders | K.L.R.M.有限公司 | 2022-11-01 | — | — | CN | disclosed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| CN-114727646-A | Novel aerosol-generating substrate comprising ginger species | 菲利普莫里斯生产公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-109923469-B | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2022-06-28 | — | — | CN | disclosed |
| EP-3328199-B1 | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | NOVUS INT INC (US) | 2022-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008806-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | RNGTT, RNMT, NSUN2 | LTA4H 1630/4885CYP3A4 4297/4885TRPV1 4658/4885 |
| US-20220356204-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | ALKBH1, DUT, RNGTT | LTA4H 2972/4885CYP3A4 3582/4885TRPV1 4045/4885 |
| US-12435105-B2 | Technologies for oligonucleotide preparation | POLRMT, DCLRE1B, RNGTT | LTA4H 3440/4885CYP3A4 4195/4885TRPV1 4776/4885 |
| US-12428442-B2 | Compounds, compositions and methods for synthesis | ALKBH1, DUT, RNGTT | LTA4H 2972/4885CYP3A4 3582/4885TRPV1 4045/4885 |
| US-20260055133-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS | NSUN2, NSUN3, NOP2 | LTA4H 3608/4885CYP3A4 3621/4885TRPV1 4198/4885 |
| US-12590115-B2 | Technologies useful for oligonucleotide preparation | NOP2, RNGTT, NSUN2 | LTA4H 2891/4885CYP3A4 4254/4885TRPV1 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.